![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
The impurity was identified following laboratory testing conducted by the Food and Drug Administration (FDA); this is the first non-valsartan product that the Agency has found to contain NDEA.
FDA approves Novartis’ copy of AbbVie bestseller Humira
The U.S. Food and Drug Administration (FDA) has approved Novartis AG’s copy of Humira, the world’s bestselling prescription medicine developed by U.S.-based AbbVie Inc, the agency’s website showed on...
Severe Acute Respiratory Distress Syndrome Following HCTZ Administration
“One of the most commonly prescribed antihypertensives, HCTZ is associated with rare cases of pulmonary edema, which typically develop within minutes to hours of the initial dose of the medication,” the...
Slechts kwart psoriasispatiënten naar huisarts met deze klacht in 2017
In 2017 vond behandeling van psoriasis voornamelijk plaats bij een medisch specialist; slechts 27% van de patiënten met psoriasis bezocht de huisarts met deze klacht. Psoriasis is een veel voorkomende chronische...
Medical cannabis products available on prescription
The treatments can only be prescribed by specialist doctors and will not be available through GPs.
‘Don’t be taken in by anti-vaccine myths on social media’
Parents should ignore the myths and get their children vaccinated, the chief medical officer says.
UA scientists aim to identify drug targets for rare pediatric cancer
Rhabdomyosarcoma is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the...
FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about...
How antibiotic resistance could take us back to the ‘dark ages’
There are major concerns that the overuse of the drugs might lead to them becoming ineffective.
J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk
The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of major adverse cardiovascular (CV) events, making it the “first and only oral diabetes treatment...
Dupixent helps put Sanofi back on growth track
French drugs giant sees an 8% rise in vaccine sales
Vijf misverstanden over faillissement ziekenhuis
Het failliet van de MC Groep en daarmee van zowel MC Slotervaart als de IJsselmeerziekenhuizen is een feit. De afgelopen week heb ik zoveel desinformatie zien langskomen dat ik in deze blog de vijf meestvoorkomende op...
‘Eerst doelen bepalen, dan keuzes maken in de zorg’
Keuzes over vergoeding van behandelingen of verdeling van geld in de zorg worden nu vaak gebaseerd op emoties, lobby en nabijheid van patiënten, constateert De Vries. ‘Kijk bijvoorbeeld naar het besluit tot...
De hechte relatie tussen marketingstrategie en businessmodel
Er wordt vaak gesproken over businessmodellen en de relevantie ervan. Maar wat is de relatie met marketing en is deze er ook? Het antwoord is absoluut JA! Patrick Kooij belicht in een serie blogs de relevantie tussen...
FDA approves ultra-high-field 7T Terra MRI scanner for clinical use
The ultra-high-field 7T Terra magnetic resonance imaging scanner at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute of the Keck School of Medicine of USC has received FDA approval for clinical use...
First shared Swiss platform to promote regenerative medicine launched in Bern
Regenerative Medicine is one of the fastest growing sectors in biomedical research – replacing diseased cells, tissues or organs.
Pfizer manufacturing ills mean ongoing shortages for hospitals
Pfizer acknowledged Tuesday that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill not just for investors but also for U.S. hospitals. The manufacturing problems at Hospira that...
Sales Accelerant rebrands as The Healthcare Partnership
Offers brand implementation to the pharma industry
